Comparative of the effectiveness and safety of biological agents, small molecule drugs, and microbiome therapies in ulcerative colitis: Systematic review and network meta-analysis

BACKGROUND: Biological agents are commonly used for the first-line treatment of ulcerative colitis (UC). However, small-molecule drugs and microbiome therapies are now being used as new treatments for ulcerative colitis. We aimed to compare the relative efficacy and safety of biologics, small-molecu...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Jie, Nie, Rui, Chen, Yalan, Yang, Wei, Ren, Qian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10615430/
https://www.ncbi.nlm.nih.gov/pubmed/37904440
http://dx.doi.org/10.1097/MD.0000000000035689

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10615430/
https://www.ncbi.nlm.nih.gov/pubmed/37904440
http://dx.doi.org/10.1097/MD.0000000000035689

Ejemplares similares